RAFFA WEALTH MANAGEMENT, LLC’s Ultragenyx Pharmaceutical RARE Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21	Closed	-$440	–	1665
2026 Q1	$440	Hold	21	–	–	﹤0.01%	1085
2025 Q4	$483	Hold	21	–	–	﹤0.01%	1073
2025 Q3	$632	Hold	21	–	–	﹤0.01%	1006
2025 Q2	$764	Hold	21	–	–	﹤0.01%	921
2025 Q1	$760	Hold	21	–	–	﹤0.01%	890
2024 Q4	$883	Hold	21	–	–	﹤0.01%	895
2024 Q3	$1.17K	Hold	21	–	–	﹤0.01%	809
2024 Q2	$863	Hold	21	–	–	﹤0.01%	938
2024 Q1	$980	Hold	21	–	–	﹤0.01%	905
2023 Q4	$1K	Hold	21	–	–	﹤0.01%	824
2023 Q3	$749	Hold	21	–	–	﹤0.01%	862
2023 Q2	$969	Hold	21	–	–	﹤0.01%	798
2023 Q1	$842	Hold	21	–	–	﹤0.01%	839
2022 Q4	$973	Hold	21	–	–	﹤0.01%	787
2022 Q3	$870	Hold	21	–	–	﹤0.01%	845
2022 Q2	$1.25K	Hold	21	–	–	﹤0.01%	740
2022 Q1	$1.52K	Hold	21	–	–	﹤0.01%	718
2021 Q4	$1.77K	Hold	21	–	–	﹤0.01%	692
2021 Q3	$1.89K	Hold	21	–	–	﹤0.01%	629
2021 Q2	$2K	Hold	21	–	–	﹤0.01%	624
2021 Q1	$2.39K	Hold	21	–	–	﹤0.01%	587
2020 Q4	$2.91K	Hold	21	–	–	﹤0.01%	462
2020 Q3	$1.73K	Sell	21 -1	-5%	-$83	﹤0.01%	523
2020 Q2	$1.72K	Hold	22	–	–	﹤0.01%	508
2020 Q1	$977	Sell	22 -8	-27%	-$415	﹤0.01%	601
2019 Q4	$1.28K	Buy	30 +17	+131%	+$701	﹤0.01%	526
2019 Q3	$556	Buy	+13	New	+$706	﹤0.01%	715
2019 Q2	–	Sell	-13	Closed	-$902	–	1240
2019 Q1	$902	Hold	13	–	–	﹤0.01%	606
2018 Q4	$565	Hold	13	–	–	﹤0.01%	713
2018 Q3	$992	Buy	+13	New	+$1.06K	﹤0.01%	613
2017 Q3	–	Sell	-10	Closed	-$621	–	365
2017 Q2	$621	Hold	10	–	–	﹤0.01%	388
2017 Q1	$678	Hold	10	–	–	﹤0.01%	362
2016 Q4	$703	Hold	10	–	–	﹤0.01%	578
2016 Q3	$709	Buy	10 +4	+67%	+$255	﹤0.01%	548
2016 Q2	$293	Hold	6	–	–	﹤0.01%	833
2016 Q1	$380	Hold	6	–	–	﹤0.01%	768
2015 Q4	$673	Hold	6	–	–	﹤0.01%	531
2015 Q3	$578	Buy	+6	New	+$687	﹤0.01%	603

Other funds holding RARE

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

OAM

OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's RARE Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC sold out of Ultragenyx Pharmaceutical (RARE) in Q2 2026, closing a stake of 21 shares — an estimated $440 sold.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in RARE in Q3 2015 and held it in 38 quarters. The position peaked at $2.91K in Q4 2020. 46 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC reported no remaining Ultragenyx Pharmaceutical position as of Q2 2026 after selling out during the quarter.
RAFFA WEALTH MANAGEMENT, LLC sold 21 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $440.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in Ultragenyx Pharmaceutical in Q3 2015 and held it in 38 quarters.
RAFFA WEALTH MANAGEMENT, LLC's Ultragenyx Pharmaceutical position peaked at $2.91K in Q4 2020.
46 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.